Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
10/24/2000 | US6136310 Recombinant anti-CD4 antibodies for human therapy |
10/24/2000 | US6136294 Amino acid stabilized medical aerosol formulation |
10/19/2000 | WO2000061788A2 Poly(dipeptide) as a drug carrier |
10/19/2000 | WO2000061774A2 Bone morphogenic proteins |
10/19/2000 | WO2000061750A2 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS |
10/19/2000 | WO2000061748A1 48 human secreted proteins |
10/19/2000 | WO2000061620A1 49 human secreted proteins |
10/19/2000 | WO2000061608A2 Low-molecular inhibitors of complement proteases |
10/19/2000 | WO2000061604A2 Pharmaceutical compounds |
10/19/2000 | WO2000061596A1 50 human secreted proteins |
10/19/2000 | WO2000061583A1 Xanthine derivatives and analogs as cell signaling inhibitors |
10/19/2000 | WO2000061580A1 Substituted bicyclic heteroaryl compounds as integrin antagonists |
10/19/2000 | WO2000061579A1 New endothelin converting enzyme inhibitors, their production and their use |
10/19/2000 | WO2000061569A1 Adamantane derivatives |
10/19/2000 | WO2000061554A1 1-amino ethylindole derivatives for the treatment of urinary incontinence |
10/19/2000 | WO2000061553A1 2-aminoethyl-indole derivatives, their preparation and therapeutic use |
10/19/2000 | WO2000061541A2 Pharmaceutical compounds |
10/19/2000 | WO2000061233A2 Methods and compositions for the treatment and prevention of lung disease involving a specific rar-gamma agonist |
10/19/2000 | WO2000061232A2 Methods and compositions for the treatment and prevention of lung disease involving a specific rar-beta antagonist |
10/19/2000 | WO2000061221A1 Method of providing cosmetic/medical therapy |
10/19/2000 | WO2000061182A2 Methods and compositions for the treatment and prevention of lung disease involving a selective rar-alpha agonist |
10/19/2000 | WO2000041505A3 Anthranilic acid derivatives |
10/19/2000 | WO2000033872A3 Method of and compositions for immunization with the pseudomonas v antigen |
10/19/2000 | WO2000013702A9 Use of an angiogenic factor for the treatment of microvascular angiopathies |
10/19/2000 | WO2000012720A8 Elongase genes and uses thereof |
10/19/2000 | DE19917505A1 Treating cytokine-mediated diseases, e.g. asthma, allergy, eczema, rheumatoid arthritis or transplant rejection, using new or known maduraphthalazine derivatives |
10/19/2000 | DE19916719A1 Neue ECE-Inhibitoren, ihre Herstellung und Verwendung New ECE inhibitors, their preparation and use |
10/19/2000 | CA2371172A1 50 human secreted proteins |
10/19/2000 | CA2370767A1 49 human secreted proteins |
10/19/2000 | CA2370425A1 Pharmaceutical compounds |
10/19/2000 | CA2369981A1 Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same |
10/19/2000 | CA2369728A1 Substituted bicyclic heteroaryl compounds as integrin antagonists |
10/19/2000 | CA2369378A1 Low-molecular inhibitors of complement proteases |
10/19/2000 | CA2369029A1 Poly(dipeptide) as a drug carrier |
10/19/2000 | CA2368829A1 Adamantane derivatives |
10/19/2000 | CA2365917A1 Bone morphogenic proteins |
10/19/2000 | CA2365905A1 48 human secreted proteins |
10/19/2000 | CA2365623A1 Tyrosine kinase substrate (tks) proteins |
10/19/2000 | CA2356128A1 Method of providing cosmetic/medical therapy |
10/18/2000 | EP1044273A2 COMPOSITIONS DERIVED FROM $i(MYCOBACTERIUM VACCAE) AND METHODS FOR THEIR USE |
10/18/2000 | EP1044215A1 Anti-inflammatory phenylalanine derivatives |
10/18/2000 | EP1044211A1 36 human secreted proteins |
10/18/2000 | EP1044201A1 3-substituted adenines via2-thioxanthines |
10/18/2000 | EP1044024A1 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
10/18/2000 | EP1043995A1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS |
10/18/2000 | EP1043978A1 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
10/18/2000 | EP1043973A1 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant |
10/18/2000 | EP1043930A1 Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids |
10/18/2000 | EP0850215B1 N-(aroyl)glycine hydroxamic acid derivatives and related compounds |
10/18/2000 | CN1270591A Novel compounds |
10/18/2000 | CN1270590A Novel compounds |
10/18/2000 | CN1270515A Methods and compositions for treating pulmonary disorders using optically pure(S)-salmeterol |
10/18/2000 | CN1270027A Stable aqueous solution of phthalylglutamic acidimide derivative |
10/18/2000 | CN1057455C Chinese medicine composite for curing bronchial disease |
10/17/2000 | US6133479 Phenylethylamine derivatives, processes for preparing them and their use as pharmaceutical compositions |
10/17/2000 | US6133319 For treating an interleukin-8 (il-8) mediated disease by administering a phenyl urea or phenyl thiourea of given formula, such as n-cyclohexyl-n'-(2-hydroxy-4-nitrophenyl)urea |
10/17/2000 | US6133309 Treatment of T-helper cell type 2-mediated immune disease by retinoid antagonists |
10/17/2000 | US6133286 Antagonists; antiinflammatory agents for rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, psoriasis and other skin disorders, e.g., eczema, erythema, pruritus and acne; stroke, reperfusion injury, grafting |
10/17/2000 | US6133272 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
10/17/2000 | US6133257 Fused polycyclic 2-aminopyrimidine derivatives |
10/17/2000 | US6133247 Method of detecting lung disease |
10/17/2000 | US6133240 Tetrahydronapthalene derivatives and their therapeutic use |
10/17/2000 | US6132987 Polypeptide associated with macrophages; for diagnosis and treatment of inflammation, arthritis and atherosclerosis |
10/17/2000 | US6131566 Metered dose inhaler for albuterol |
10/17/2000 | US6131226 1,4-dihydropyridine compounds as bradykinin antagonists |
10/17/2000 | CA2305893A1 Use of maduraphthalazine derivatives as inhibitors of proinflammatory cytokines |
10/17/2000 | CA2009221C Spray preparations for respiratory tract infections |
10/12/2000 | WO2000060117A2 Prediction of risk of interstitial lung disease |
10/12/2000 | WO2000060082A2 Vesicle associated proteins |
10/12/2000 | WO2000060080A2 Molecules of the immune system |
10/12/2000 | WO2000060051A2 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
10/12/2000 | WO2000059904A2 Compounds and methods to treat cardiac failure and other disorders |
10/12/2000 | WO2000059901A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase |
10/12/2000 | WO2000059889A1 α-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES |
10/12/2000 | WO2000059886A2 Benzimidazole abd imidazolophyridine derivaties, their preparation and their use as selective modulators of bradykinin b2 (=bk-2) receptors |
10/12/2000 | WO2000059873A1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists |
10/12/2000 | WO2000059548A1 Polyethyleneimine:dna formulations for aerosol delivery |
10/12/2000 | WO2000059520A1 Herbal compositions and uses for the treatment of allergic reactions |
10/12/2000 | WO2000059506A1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
10/12/2000 | WO2000059503A1 Pyrrolidine modulators of chemokine receptor activity |
10/12/2000 | WO2000059502A1 Pyrrolidine modulators of chemokine receptor activity |
10/12/2000 | WO2000059495A1 (e)-styryl sulfone anticancer agents |
10/12/2000 | WO2000059483A2 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
10/12/2000 | WO2000059468A1 Drinkable pharmaceutical solution |
10/12/2000 | WO2000059449A2 Purine derivatives having phosphodiesterase iv inhibition activity |
10/12/2000 | WO2000035939A3 Connective tissue growth factor fragments and methods and uses thereof |
10/12/2000 | WO2000033811A3 Improvements in or relating to powders |
10/12/2000 | WO2000025722A3 ENHANCED VACCINES COMPRISING SELF AND NON-SELF IgE PORTIONS OR DIMERIC ANTIGENS |
10/12/2000 | WO1999064039A9 Bradykinin antagonists |
10/12/2000 | WO1999051188A9 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
10/12/2000 | CA2373717A1 Pyrrolidine modulators of chemokine receptor activity |
10/12/2000 | CA2369871A1 .alpha.-substituted carboxylic acid derivatives |
10/12/2000 | CA2369544A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives:selective modulators of bradykinin b2 receptors |
10/12/2000 | CA2368686A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase |
10/12/2000 | CA2368240A1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists |
10/12/2000 | CA2368185A1 Polyethyleneimine:dna formulations for aerosol delivery |
10/12/2000 | CA2367378A1 Molecules of the immune system |
10/12/2000 | CA2367294A1 Prediction of risk of interstitial lung disease |
10/12/2000 | CA2367143A1 Purine derivatives having phosphodiesterase iv inhibition activity |
10/12/2000 | CA2367100A1 Transdermal drug delivery devices comprising a polyurethane drug reservoir |